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Abstract: Infectious diseases are responsible for signifi-
cant disease burden in the Pacific Islands. Environmen-
tal drivers of disease transmission and public health 
challenges vary between diseases, at times of emergence 
versus outbreaks, and also during the last stages of elimi-
nation where prevalence is low.  In order to more effec-
tively combat infectious diseases in the region, innovative 
approaches such as sentinel surveillance, environmental 
monitoring, the use of geospatial tools should be explored.
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Introduction
Infectious diseases are responsible for significant morbid-
ity and mortality in the Pacific Islands (1). The region is 
vulnerable to outbreaks because of many reasons, includ-
ing the tropical climate that provides a favourable environ-
ment for pathogens; relatively poor sanitation, hygiene, 
and vector control; increasing frequency of extreme 
weather like cyclones and floods associated with climate 
change; and limited human and financial resources to 
mitigate and respond to outbreaks (2). Such outbreaks 
not only cause significant disease burden but could also 
place enormous stress on health systems and result in 
huge socioeconomic losses for already fragile economies. 
In addition, isolated human populations are vulnerable 
to severe epidemics when new pathogens attack immu-
nologically naïve populations and cause a ‘virgin soil 
epidemics’ (3). Furthermore, low biodiversity and delicate 
ecosystems on remote islands render them vulnerable 
to invasion by vectors (e.g., rodents) (4) and associated 
pathogens, leading to emergence of infectious diseases. 
Elimination programs for diseases like lymphatic filariasis 
(5) have significantly reduced disease incidence in some 
Pacific Islands; however, there are continuing challenges 
to ensure that elimination is sustained, including surveil-
lance and management of resurgence and/or reintroduc-
tion through movement of infected people between the 
islands (6). The environmental drivers of disease trans-
mission and public health challenges vary between dis-
eases, at times of emergence versus outbreaks, and also 
during the last stages of elimination where prevalence is 
low. This article discusses some of the challenges faced 
when combating a few of the important infectious dis-
eases in the Pacific Islands, and discuss a few relatively 
novel approaches to providing an evidence base and 
improving knowledge about infectious disease epidemiol-
ogy and transmission. Such knowledge would be valuable 
for directing public and environmental health interven-
tions to reduce disease burden associated with disease 
emergence and outbreaks, and inform optimal endgame 
strategies for elimination.
Disease emergence and outbreaks
Small remote islands are vulnerable to invasion by new 
pathogens, and isolated communities are highly sus-
ceptible to severe epidemics when new infections are 
introduced to the immunologically naïve population (3). 
Transportation of new pathogens could occur through the 
frequent movement of people between the Pacific Islands, 
and also from other parts of the world through the increas-
ing growth in international travel and trade. Many Pacific 
Islands lack laboratory capacity to identify novel patho-
gens or real-time surveillance systems to provide early 
warning, thus increasing the opportunity for outbreaks 
to ‘escape’ before effective public health interventions 
could be instituted. In addition, acute febrile illnesses are 
common in the Pacific Islands and often treated empiri-
cally based on clinical judgement, without the oppor-
tunity for laboratory confirmation of diagnosis. All the 
above factors combine to create an environment where 
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novel pathogens could rapidly result in disease emer-
gence and large outbreaks.
Arboviral infections provide striking examples that 
‘virgin soil outbreaks’ are not just a theoretical concept. 
The combination of tropical climate, high rainfall, effi-
cient vectors, favourable mosquito-breeding habitats, and 
outdoor lifestyle all contribute to the high risk of trans-
mission. With global climate change and predictions of 
increasing frequency and severity of cyclones and flood-
ing, together with population growth, urbanisation, and 
rising international travel, the threat of arboviral outbreaks 
loom large. Dengue is endemic throughout the region (7) 
and probably under-diagnosed and under-reported owing 
to poor laboratory capacity and inadequate surveillance 
systems (8). A recent study in American Samoa found a 
dengue seroprevalence of  > 95%, signifying almost univer-
sal exposure and infection (9). Other important arboviral 
infections that receive less attention include Ross River 
Virus and Chikungunya – both pathogens cause overlap-
ping clinical symptoms and signs with dengue, and could 
potentially be misdiagnosed clinically as dengue where 
laboratory confirmation is unavailable.
In 1979–1980, a Ross River virus outbreak in the 
Pacific Islands resulted in  > 500,000 cases and affected 
90% of the population in Fiji, 69% in the Cook Islands, 
44% in American Samoa, and 33% in New Caledonia 
(10–12). The newly introduced virus was thought to have 
arrived via a viraemic Australian traveller to Fiji, and 
is likely to still be circulating at low levels (13). Over 
30 years have passed since the epidemic, and the number 
of non-immune young people who were not yet born in 
1980 will continue to grow, thus increasing the risk of 
future epidemics. In 2005, a Chikungunya outbreak 
in the Indian Ocean islands caused  > 250,000 cases in 
La Réunion (14). Since then, the virus has spread fero-
ciously across the Indian subcontinent and Southeast 
Asia, causing significant morbidity for many millions of 
people (15). Recent local transmission of Chikungunya 
was reported in New Caledonia in 2011 (16), thus far the 
only evidence of locally acquired infection in the Pacific 
Islands. The outbreak was fortunately interrupted by 
timely public health response; however, most Pacific 
Islands do not have laboratory capability to diagnose 
Chikungunya or the capacity to respond adequately. Chi-
kungunya continues to pose the threat of an epidemic in 
the region, and it is possible that undetected incursion 
might already have occurred in places where laboratory 
diagnosis is unavailable.
Some infectious diseases are already well established 
in the region; however, outbreaks are occurring with 
increasing frequency as a result of environmental change, 
with drivers of transmission related to both the natural 
environment (e.g., climate, rainfall) and the anthropo-
genic environment (e.g., overcrowding, urbanisation). For 
example, leptospirosis is identified as one of the climate-
sensitive infectious diseases in Fiji, and currently the focus 
of a World Health Organization-funded research project 
aimed at developing early warning systems for outbreaks 
(17). Leptospirosis is a zoonotic disease with complex 
transmission dynamics involving the interaction between 
humans, animal reservoirs, and the environment. Human 
behaviour plays an important role in determining expo-
sure to infection (18); however, the transmission of lepto-
spirosis is also strongly driven by environmental factors 
like climate change, flooding, urbanisation, overcrowd-
ing, and poor sanitation (2). The importance of environ-
mental drivers of leptospirosis transmission in the Pacific 
Islands is evidenced by the ability to predict hotspots in 
American Samoa based purely on indicators related to the 
environment and animal populations (19). The diagnosis 
of leptospirosis in the Pacific also poses significant chal-
lenges for clinicians – infection results in a wide range of 
presentations ranging from non-specific febrile illnesses 
to multi-organ failure and death, and symptoms and signs 
overlap with arboviral infections as well as numerous 
other tropical diseases. Poor access to accurate laboratory 
diagnosis further increases the risk of misdiagnosis and 
incorrect management (20).
Disease elimination
Lymphatic filariasis (6) is one of the infections targeted for 
elimination in the Pacific. The Pacific Programme for the 
Elimination of Lymphatic Filariasis was formed in 1999 
to facilitate mass drug administration (MDA) in 22 Pacific 
Island countries and territories (5). Variable success has 
been achieved on different islands but significant pro-
gress has been made in many areas. For example, antigen 
prevalence in American Samoa has dropped from 16.5% 
in 1999 to  < 1% in 2011 after seven rounds of MDA (21). 
However, the sustained success of elimination programs 
depends on careful monitoring for potential resurgence 
after stopping MDA. Local mosquito species, like Aedes 
polynesiensis in the Samoan Islands, are highly efficient 
vectors for lymphatic filariasis; thus, disease transmission 
could potentially resurge, particularly in residual foci of 
high infection rates where there are strong environmental 
drivers of transmission. Frequent movement of infected 
people between islands could also be a potential source of 
parasite reintroduction (6).
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Elimination programs face many logistical chal-
lenges, including the improvement of community uptake 
of MDA to achieve high coverage rates, difficulties with 
reaching remote communities, the sensitivity of surveil-
lance systems to detect new and ongoing infections, and 
the limitations of diagnostic tests (6). Screening and 
treating entire populations are not cost-effective when 
prevalence is very low, and improved surveillance strat-
egies are required to optimise detection of any residual 
foci of infection and identify high-risk populations that 
could potentially be targeted for screening and treat-
ment. Operational research is required to determine 
the most efficient and cost-effective endgame strate-
gies for elimination programs and to reduce the risk of 
resurgence.
Some innovative strategies for 
combating infectious diseases
Surveillance by proxy
To detect and manage novel pathogens in a timely and 
effective manner, it is necessary to improve the avail-
ability of laboratory diagnosis as well as surveillance 
systems in the region. If limited resources preclude 
the availability of laboratory tests and sophisticated 
surveillance systems (e.g., in remote islands), ‘surveil-
lance by proxy’ could be a useful strategy, where diag-
noses in returned travellers are used to provide sentinel 
warning of outbreaks in the countries of disease acqui-
sition. For example, dengue surveillance data in New 
Zealand show that the patterns of reported incidence 
of dengue acquired from the Pacific Islands closely 
reflect the reported incidences in those islands where 
retrospective data were compared (8). The real-time sur-
veillance system in New Zealand could therefore poten-
tially provide early warning of dengue outbreaks in the 
Pacific Islands and facilitate more timely public health 
response.
Environmental monitoring
Many infectious disease outbreaks are precipitated by 
changes in environmental conditions, e.g., flooding 
and other natural disasters. If it was possible to accu-
rately predict disease incidence and prevalence based 
on environmental indicators, disease surveillance could 
be complemented by environmental hazard monitoring, 
which is usually cheaper and logistically simpler, thus 
providing a more cost-effective surveillance strategy (22). 
For example, recent studies have shown that leptospiro-
sis hotspots and outbreaks could potentially be predicted 
using environmental and climate data in the Pacific 
Islands (17, 19). The ability to accurately predict hotspots 
for arboviral infections based on mosquito populations 
would also be very valuable, and allow the use of vector 
monitoring to help predict outbreaks and identify poten-
tial residual hotspots during elimination.
Geographic information systems
In recent years, geographic information systems are being 
increasingly used for the investigation of the environmen-
tal drivers for infectious disease transmission, including 
micro-spatial analysis of household-level environmental 
risk factors when high-resolution data are available (19, 
23, 24). Geospatial databases are also potentially valu-
able for incorporating multiple sources of information on 
human health and demographics, animal and vector pop-
ulations, and environmental and climate data. Geospatial 
analysis is useful for determining hotspots for disease 
transmission, and developing innovative tools like predic-
tive risk charts and maps to inform public health resource 
allocation (19, 24). Spatial decision support systems are 
also playing an increasingly important role in elimination 
programs (25).
Integrated environmental health impact 
assessment
For pathogens that have complex transmission cycles 
(e.g., zoonotic and arthropod-borne diseases), a multi-
disciplinary approach is crucial for understanding the 
eco-epidemiology of disease transmission. An example 
of such an approach is an integrated environmental 
health impact assessment (IEHIA) that enhances the 
ability to quantify associations between a pathogen 
and its health impact by taking into account the envi-
ronmental drivers of transmission, human behaviour, 
socioeconomic factors, and the multiple pathways 
through which exposure and infection could occur. An 
IEHIA approach is useful for improving the understand-
ing of complex environmental health problems that 
involve multiple layers of hazards, exposure pathways, 
and data sources; and combine elements of epidemi-
ology, risk analysis, and impact assessment (26, 27). 
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Conceptual frameworks are used to define the scope of 
the study; identify hazards; determine exposure path-
ways and interactions between different elements of the 
transmission cycle (e.g., humans, animals, mosquitoes, 
environment); select indicators of risk; and link poten-
tial sources of data, including geospatial data. Statis-
tical modelling could be used to quantify the current 
health impact of each disease and provide a baseline or 
reference scenario, and future health impact could be 
predicted based on possible alternative scenarios like 
changes in environment and demographics, or imple-
mentation of interventions (26, 27). Predictive modelling 
could also be used to estimate current disease burden, 
and predict future burden based on changes in popula-
tion demographics and distribution. An IEHIA approach 
also stimulates interdisciplinary collaboration, which 
is crucial for investigating and managing complex envi-
ronmental health problems.
Conclusion
Combating infectious diseases in the Pacific Islands 
poses many challenges. Improved diagnostics and sur-
veillance systems are required to improve the accuracy 
of clinical diagnosis and epidemiologic information. 
Intimate links between the environment and infectious 
disease transmission necessitates that environmental 
health is not forgotten when managing disease emer-
gence, outbreaks, as well as elimination. Innovative 
methods and strategies are required to more effectively 
monitor, investigate, and predict infectious disease 
transmission, and provide an evidence base to direct 
public health and environmental health interventions 
aimed at reducing disease burden.
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